Get started
Pressure BioSciences, Inc.Pressure BioSciences, Inc.Pressure BioSciences, Inc.

Pressure BioSciences, Inc.

No trades
See on Supercharts
Overview
Financials News Ideas Discussions Technicals Seasonals

PBIO chart


Full chart

PBIO upcoming earnings

Next report date
—
Report period
—
EPS estimate
—
Revenue estimate
—

Key stats


Market capitalization
‪93.45 K‬ USD
Dividend yield (indicated)
—
Price to earnings Ratio (TTM)
—
Basic EPS (TTM)
−1.3758 USD
Net income (FY)
‪−29.31 M‬ USD
Revenue (FY)
‪1.98 M‬ USD
Shares float
‪37.02 M‬
Beta (1Y)
−11.14

Employees


Employees (FY)
16
Change (1Y)
−1 −5.88%
Revenue / Employee (1Y)
‪123.61 K‬ USD
Net income / Employee (1Y)
‪−1.83 M‬ USD

About Pressure BioSciences, Inc.


Sector
Health Technology
Industry
Medical Specialties
CEO
Richard T. Schumacher
Website
pressurebiosciences.com
Headquarters
Canton
Founded
1978
FIGI
BBG000HKMCF9
Pressure BioSciences, Inc. engages in the manufacture and distribution of infectious disease diagnostic products. It provides pressure-based platform solutions for the worldwide life sciences industry. Its products include barocyclers, barocycler accessories, external pressure calibration device kit, microtubes for barocyclers, microtube accessories for barocyclers, baroshear K45, hub high pressure generators and accessories, HP cell from ISS, RF1700 mini ultra-high pressure pump, shredder SG3 and shredder tubes, and service contracts. It offers its products under the brands Barocycler, PULSE, BioSeq, ProteoSolve, ProteoSolveLRS, Power of PCT, PCT Shredder, HUB440, HUB880, micro- Pestle, PCT-HD, BaroFold, Barozyme, BaroFlex, and Strips. The company was founded by Richard T. Schumacher in August 1978 and is headquartered in Canton, MA.

Financials


Performance
Revenue to profit conversion
Debt level and coverage
Earnings
Next:—

PBIO news



Ideas



See all ideas 

Technicals

Summarizing what the indicators are suggesting.
Oscillators
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Oscillators
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Summary
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Summary
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Summary
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Moving Averages
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Moving Averages
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy

Seasonals


Displays a symbol's price movements over previous years to identify recurring trends.

Frequently Asked Questions


The current price of PBIO is 0.0035 USD — it hasn't changed in the past 24 hours. Watch Pressure BioSciences, Inc. stock price performance more closely on the chart.
Depending on the exchange, the stock ticker may vary. For instance, on OTC exchange Pressure BioSciences, Inc. stocks are traded under the ticker PBIO.
PBIO stock hasn't changed in a week, the month change is a −44.44% fall, over the last year Pressure BioSciences, Inc. has showed a −99.00% decrease.
PBIO reached its all-time high on Feb 9, 2000 with the price of 509.5716 USD, and its all-time low was 0.0005 USD and was reached on Nov 18, 2024. View more price dynamics on PBIO chart.
See other stocks reaching their highest and lowest prices.
PBIO stock is 40.00% volatile and has beta coefficient of −11.14. Track Pressure BioSciences, Inc. stock price on the chart and check out the list of the most volatile stocks — is Pressure BioSciences, Inc. there?
Yes, you can track Pressure BioSciences, Inc. financials in yearly and quarterly reports right on TradingView.
Pressure BioSciences, Inc. is going to release the next earnings report on Feb 26, 2025. Keep track of upcoming events with our Earnings Calendar.
PBIO net income for the last quarter is ‪−8.07 M‬ USD, while the quarter before that showed ‪−9.90 M‬ USD of net income which accounts for 18.47% change. Track more Pressure BioSciences, Inc. financial stats to get the full picture.
No, PBIO doesn't pay any dividends to its shareholders. But don't worry, we've prepared a list of high-dividend stocks for you.
As of Dec 27, 2024, the company has 16.00 employees. See our rating of the largest employees — is Pressure BioSciences, Inc. on this list?
EBITDA measures a company's operating performance, its growth signifies an improvement in the efficiency of a company. Pressure BioSciences, Inc. EBITDA is ‪−7.17 M‬ USD, and current EBITDA margin is −474.82%. See more stats in Pressure BioSciences, Inc. financial statements.
Like other stocks, PBIO shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade Pressure BioSciences, Inc. stock right from TradingView charts — choose your broker and connect to your account.
Investing in stocks requires a comprehensive research: you should carefully study all the available data, e.g. company's financials, related news, and its technical analysis. So Pressure BioSciences, Inc. technincal analysis shows the neutral today, and its 1 week rating is sell. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1 month rating Pressure BioSciences, Inc. stock shows the sell signal. See more of Pressure BioSciences, Inc. technicals for a more comprehensive analysis.
If you're still not sure, try looking for inspiration in our curated watchlists.